Bar-Ilan University has joined a major new €8 million European initiative aimed at revolutionizing how personalized cancer treatments like CAR-T cell therapy are delivered in hospitals. Funded by the EU-backed Innovative Health Initiative (IHI), the five-year project—called EASYGEN (Easy workflow integration for gene therapy)—will develop a fully automated system that allows hospitals to manufacture CAR-T therapies on-site in just 24 hours instead of weeks.

A new study has identified three distinct molecular subtypes of follicular lymphoma (FL), offering insights that may shape future precision diagnostics and personalized treatment plans for patients across Asia and the West.

The research was jointly conducted by scientists at BGI Genomics' Institute of Intelligent Medical Research (IIMR) and Sweden's Karolinska Institutet, published in Cell Reports Medicine early August.

Key takeaways

UCLA researchers have created a first-of-its-kind blueprint that captures how the ovarian reserve — a female’s lifetime supply of eggs — forms in primates.

The work provides the first cellular explanation for mini-puberty, a discovery that could serve as an early biomarker for identifying those at risk of ovarian dysfunction.

Armed with this new manual, scientists can now create more sophisticated and accurate 3D ovarian models, advancing the development of better treatments for infertility and hormonal disorders that affect millions of women worldwide.